A cancer drug candidate that, rightly or wrongly, became a flashpoint at FDA, fails on a second try at approval.
US regulators have withdrawn their approval of a GSK Plc drug that the Trump administration had promoted as a treatment for ...
Espresso Malted Milk Balls sold nationwide were recalled after undeclared wheat and soy were found. The FDA classified the ...
The second time is not the charm for Replimune’s melanoma candidate RP1. | The second time is not the charm for Replimune’s ...
The U.S. Food and Drug Administration on Friday declined to approve Replimune's drug for advanced skin cancer, ...
GSK discontinued Wellcovorin in 1999, but the FDA in September last year asked the pharma to refile an application, pointing ...
FDA issues guidance compounded GLP-1 production limits, restricting pharmacies to compound only during active shortages to ensure drug safety and ...
A CNBC investigation revealed the proliferation of AFPs, which import prescription drugs from overseas in what U.S.
FDA Commissioner Marty Makary has said the agency needs “giant, big ideas” to counter China’s dominance in early-stage ...
Under the new priority voucher program (CNPV), the FDA has approved a new oral GLP-1 drug, Foundayo, offering an alternative ...
April 8 (Reuters) - The U.S. Food and Drug Administration has told medical device maker Medline that its syringes used in ...
Abbisko Cayman (SEHK:2256) is in focus after Abbisko Therapeutics reported U.S. FDA clearance of an IND application for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results